T. Rowe Price Health Sciences Fund, Inc. VRNA Holdings History
T. Rowe Price Health Sciences Fund, Inc.'s Verona Pharma PLC Holding Summary
As of 2025-03-31, T. Rowe Price Health Sciences Fund, Inc. held 1.37 Mil shares of Verona Pharma PLC(VRNA), totaling $86.79 Mil. This investment constitutes 0.76% of their stock portfolio, and T. Rowe Price Health Sciences Fund, Inc. now holds 1.61% of the outstanding Verona Pharma PLC(VRNA) stock.
The initial trade took place in 2025Q1. And since then T. Rowe Price Health Sciences Fund, Inc. has made 1 purchases of VRNA, at an average price of $59.82, for a total of 1.37 Mil shares. Based on historical transaction data and VRNA's current price of $104.93, T. Rowe Price Health Sciences Fund, Inc.'s estimated gain on his VRNA holdings is $61.66 Mil, reflecting a 75.40% gain to date.
T. Rowe Price Health Sciences Fund, Inc. VRNA ($104.93) Holding Chart
T. Rowe Price Health Sciences Fund, Inc. VRNA ($104.93) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
